The oncometabolite 2-hydroxyglutarate activates the mTOR signalling pathwayMélissa Carbonneau, Frédérick A. Mallette, Alena Motorina et al.|Nature Communications|2016Cited by 179
Translational and HIF1α-dependent metabolic reprograming underpin oncometabolome plasticity and synergy between oncogenic kinase inhibitors and biguanidesLaura Hulea, Ivan Topisirović|bioRxiv (Cold Spring Harbor Laboratory)|2017Cited by 0